96 related articles for article (PubMed ID: 9130628)
21. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis.
Liu YJ; Mason DY; Johnson GD; Abbot S; Gregory CD; Hardie DL; Gordon J; MacLennan IC
Eur J Immunol; 1991 Aug; 21(8):1905-10. PubMed ID: 1868875
[TBL] [Abstract][Full Text] [Related]
22. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.
Aggarwal S; Gupta S
J Immunol; 1998 Feb; 160(4):1627-37. PubMed ID: 9469419
[TBL] [Abstract][Full Text] [Related]
23. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients.
Marie J; Wakkach A; Coudray A; Chastre E; Berrih-Aknin S; Gespach C
J Immunol; 1999 Feb; 162(4):2103-12. PubMed ID: 9973484
[TBL] [Abstract][Full Text] [Related]
24. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
Walker A; Taylor ST; Hickman JA; Dive C
Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
[TBL] [Abstract][Full Text] [Related]
25. Cryptorchidism induces mouse testicular germ cell apoptosis and changes in bcl-2 and bax protein expression.
Xu J; Xu Z; Jiang Y; Qian X; Huang Y
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):25-33. PubMed ID: 10905505
[TBL] [Abstract][Full Text] [Related]
26. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
[TBL] [Abstract][Full Text] [Related]
28. The activation of caspase-3 and DNA fragmentation in B cells phagocytosed by macrophages.
Ninomiya E; Ito Y; Shibata MA; Kawashima K; Sakamoto T; Maruyama E; Doi H; Tokitsu K; Otsuki Y
Med Electron Microsc; 2003 Jun; 36(2):87-93. PubMed ID: 12825121
[TBL] [Abstract][Full Text] [Related]
29. Inhibited apoptosis of synovial fluid lymphocytes in children with juvenile idiopathic arthritis is associated with increased expression of myeloid cell leukemia 1 and XIAP proteins.
Smolewska E; Stanczyk J; Robak T; Smolewski P
J Rheumatol; 2006 Aug; 33(8):1684-90. PubMed ID: 16881124
[TBL] [Abstract][Full Text] [Related]
30. Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC.
Zuckerman NS; Howard WA; Bismuth J; Gibson K; Edelman H; Berrih-Aknin S; Dunn-Walters D; Mehr R
Eur J Immunol; 2010 Apr; 40(4):1150-61. PubMed ID: 20104489
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection.
Boudet F; Lecoeur H; Gougeon ML
J Immunol; 1996 Mar; 156(6):2282-93. PubMed ID: 8690919
[TBL] [Abstract][Full Text] [Related]
32. Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1983 Nov; 54(2):378-86. PubMed ID: 6317238
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte subpopulations in non-neoplastic thymus from myasthenia gravis patients.
Piantelli M; Musiani P; Lauriola L; Carbone A; Tonali P; Dina MA
Clin Exp Immunol; 1980 Jul; 41(1):19-24. PubMed ID: 6969152
[TBL] [Abstract][Full Text] [Related]
34. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
[TBL] [Abstract][Full Text] [Related]
35. CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells.
Zupo S; Rugari E; Dono M; Taborelli G; Malavasi F; Ferrarini M
Eur J Immunol; 1994 May; 24(5):1218-22. PubMed ID: 8181532
[TBL] [Abstract][Full Text] [Related]
36. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
37. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.
Gratiot-Deans J; Ding L; Turka LA; Nuñez G
J Immunol; 1993 Jul; 151(1):83-91. PubMed ID: 8326141
[TBL] [Abstract][Full Text] [Related]
38. [Apoptosis and apoptosis-related gene expression in nasopharyngeal carcinoma].
Li J; Tang A; Huang G
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):158-60. PubMed ID: 11776648
[TBL] [Abstract][Full Text] [Related]
39. TXNIP regulates germinal center generation by suppressing BCL-6 expression.
Shao Y; Kim SY; Shin D; Kim MS; Suh HW; Piao ZH; Jeong M; Lee SH; Yoon SR; Lim BH; Kim WH; Ahn JK; Choi I
Immunol Lett; 2010 Apr; 129(2):78-84. PubMed ID: 20156484
[TBL] [Abstract][Full Text] [Related]
40. The expression of Bcl-2 family proteins (Bcl-2, Bcl-x, Bax, Bak and Bim) in human lymphocytes.
Yokoyama T; Tanahashi M; Kobayashi Y; Yamakawa Y; Maeda M; Inaba T; Kiriyama M; Fukai I; Fujii Y
Immunol Lett; 2002 Apr; 81(2):107-13. PubMed ID: 11852115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
